Filing metadata

Accession number
0001193125-25-241634
Form type
Form 4
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Oct 16, 2025
Reporting period
Oct 10, 2025
Description
Insider transaction

Explore SEC Filings Hub